Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...
Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication. The drug could become a blockbuster and a key part of Vertex's portfolio. The stock has been rising in value ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a healthcare stock. It opens up new growth opportunities for the business.
To that end, Florida Tech has relaunched the underutilized Center for Advanced Manufacturing and Innovative Design as Vertex, a new "applied innovation hub." Rather than function as a traditional ...
Vertex Pharmaceuticals (VRTX) reachead $495.29 at the closing of the latest trading day, reflecting a +1.42% change compared to its last close. We recently published a list of the 11 Best Pharma ...
Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...
A list of city-owned properties, released Wednesday, were identified as suitable for bow hunting. The city also announced a permitting process for people who want to bow hunt in these areas.
MARCH OF 2023. A STATE SENATOR IS INTRODUCING A BILL TO REPEAL THE SUNDAY HUNTING BAN AND TRANSFER FULL AUTHORITY OF WILDLIFE MANAGEMENT DECISIONS TO THE GAME COMMISSION. SENATOR DAN LAUGHLIN OF ...
Anti-duck hunting groups have criticised the Victorian government's decision to allow for a longer season this year. On Friday afternoon the government announced that the 2025 hunting season would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results